BeyondSpring Inc. (BYSI)
NASDAQ: BYSI · Real-Time Price · USD
1.620
+0.220 (15.71%)
At close: Apr 1, 2025, 4:00 PM
1.530
-0.091 (-5.59%)
After-hours: Apr 1, 2025, 4:36 PM EDT
BeyondSpring Market Cap
BeyondSpring has a market cap or net worth of $65.31 million as of April 1, 2025. Its market cap has decreased by -42.25% in one year.
Market Cap
65.31M
Enterprise Value
55.52M
1-Year Change
-42.25%
Ranking
Category
Stock Price
$1.62
Market Cap Chart
Since March 9, 2017, BeyondSpring's market cap has decreased from $362.10M to $65.31M, a decrease of -81.96%. That is a compound annual growth rate of -19.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 57.90M | -11.87% |
| Dec 31, 2024 | 65.70M | 87.18% |
| Dec 29, 2023 | 35.10M | -52.05% |
| Dec 30, 2022 | 73.20M | -58.71% |
| Dec 31, 2021 | 177.30M | -52.38% |
| Dec 31, 2020 | 372.30M | -7.48% |
| Dec 31, 2019 | 402.40M | -4.76% |
| Dec 31, 2018 | 422.50M | -32.59% |
| Dec 29, 2017 | 626.80M | 73.10% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |